Thinking outside the box: non-canonical targets in multiple sclerosis

L Bierhansl, HP Hartung, O Aktas, T Ruck… - Nature reviews Drug …, 2022 - nature.com
Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system that
causes demyelination, axonal degeneration and astrogliosis, resulting in progressive …

Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders–Advances and challenges

TK Goswami, M Singh, M Dhawan, S Mitra… - Human vaccines & …, 2022 - Taylor & Francis
Autoimmune diseases are caused when immune cells act against self-protein. This
biological self–non-self-discrimination phenomenon is controlled by a distinct group of …

NK‐cell exhaustion, B‐cell exhaustion and T‐cell exhaustion—the differences and similarities

K Roe - Immunology, 2022 - Wiley Online Library
T‐cell exhaustion has been extensively researched, compared with B‐cell exhaustion and
NK‐cell exhaustion, which have received considerably less attention; and there is less of a …

Current-status and applications of polysaccharides in drug delivery systems

P Prasher, M Sharma, M Mehta, S Satija… - Colloid and Interface …, 2021 - Elsevier
The polysaccharide-based advanced drug delivery system owing to their biocompatibility,
ability to encapsulate the drug molecules in their interspaces, and ability to achieve a …

IF1 ablation prevents ATP synthase oligomerization, enhances mitochondrial ATP turnover and promotes an adenosine-mediated pro-inflammatory phenotype

S Domínguez-Zorita, I Romero-Carramiñana… - Cell Death & …, 2023 - nature.com
Abstract ATPase Inhibitory Factor 1 (IF1) regulates the activity of mitochondrial ATP
synthase. The expression of IF1 in differentiated human and mouse cells is highly variable …

Regulatory T cells (Tregs) and COVID-19: unveiling the mechanisms, and therapeutic potentialities with a special focus on long COVID

M Dhawan, AA Rabaan, S Alwarthan, M Alhajri… - Vaccines, 2023 - mdpi.com
The COVID-19 pandemic has caused havoc all around the world. The causative agent of
COVID-19 is the novel form of the coronavirus (CoV) named SARS-CoV-2, which results in …

The activation of PPARγ enhances Treg responses through up-regulating CD36/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of TβRII/IL …

Y Miao, C Zhang, L Yang, X Zeng, Y Hu, X Xue… - Cell Communication and …, 2022 - Springer
Background Peroxisome proliferator-activated receptor gamma (PPARγ) is an enhancer of
Treg responses, but the mechanisms remain elusive. This study aimed to solve this problem …

Efficacy and Safety of Mesenchymal Stem Cell Transplantation in the Treatment of Autoimmune Diseases (Rheumatoid Arthritis, Systemic Lupus Erythematosus …

L Zeng, G Yu, K Yang, W Xiang, J Li… - Stem cells …, 2022 - Wiley Online Library
Objective. To evaluate the efficacy and safety of mesenchymal stem cell (MSC)
transplantation in the treatment of autoimmune diseases. Methods. The Chinese and …

The kynurenine pathway—new linkage between innate and adaptive immunity in autoimmune endocrinopathies

A Krupa, I Kowalska - International Journal of Molecular Sciences, 2021 - mdpi.com
The kynurenine pathway (KP) is highly regulated in the immune system, where it promotes
immunosuppression in response to infection or inflammation. Indoleamine 2, 3-dioxygenase …

CAR T cells for treating autoimmune diseases

U Blache, S Tretbar, U Koehl, D Mougiakakos… - RMD open, 2023 - rmdopen.bmj.com
Autoimmune disorders occur when immune cells go wrong and attack the body's own
tissues. Currently, autoimmune disorders are largely treated by broad immunosuppressive …